Eye News and Research

Latest Eye News and Research

AIDS 2012 plenary speakers call for innovative financing, continued research for HIV cure

Speakers at Tuesday's plenary session at the XIX International AIDS Conference in Washington, D.C. highlighted the challenges that lie ahead in the response to HIV/AIDS and discussed potential solutions, ABC News reports.

26 Jul 2012

Obama skipping AIDS conference; Black community still bearing high burden of the disease

For all the dignitaries on the schedule at the International AIDS Conference this week in Washington, including Secretary of State Hillary Clinton, Microsoft Corp. co-founder Bill Gates and former President Bill Clinton, it's the absence of one that has activists talking. With the conference being held in the U.S. for the first time in 22 years, President Barack Obama is out of town campaigning and raising money for his re-election. His only presence is a 50-second cameo in a three-minute video welcoming delegates.

26 Jul 2012

Assistant Sec. of Health Koh addresses AIDS 2012 plenary; HHS Sec. Sebelius speaks at Washington Post event

Speaking at the plenary session of the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., on Monday, U.S. Assistant Secretary for Health Howard Koh discussed the development and implementation of the United States' first-ever comprehensive National HIV/AIDS Strategy, ABC News reports.

26 Jul 2012

AAQ chemical temporarily restores vision in blind mice

A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington in Seattle has discovered a chemical that temporarily restores some vision to blind mice, and is working on an improved compound that may someday allow people with degenerative blindness to see again.

26 Jul 2012

AHAF announces glaucoma and macular degeneration research grants

The American Health Assistance Foundation, a nonprofit organization with a history of funding breakthrough research on age-related vision diseases, announced today that it has awarded 21 new grants totaling $2.1 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible blindness in the world.

26 Jul 2012

Early-age cataract surgery increases central corneal thickness

When congenital cataract surgery is performed at an early age, central corneal thickness increases, show study results published in the British Journal of Ophthalmology.

25 Jul 2012

Microneedles can deliver drug formulations into the eye

Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.

24 Jul 2012

Ocular Therapeutix announces results from sustained release OTX-TP1 study on glaucoma

Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period.

24 Jul 2012

Tiny microneedles to treat macular degeneration

23 Jul 2012

Insights on neural mechanisms behind guidance of attention

Ever wonder how the human brain, which is constantly bombarded with millions of pieces of visual information, can filter out what's unimportant and focus on what's most useful?

23 Jul 2012

Noted philanthropist to launch mobile eye clinic in North India

Noted entrepreneur and philanthropist, Tej Kohli is all set to launch Drishti Rath, a complete eye clinic on wheels. After the successful launch of the corneal blindness eradication programme in 2010, which enabled hundreds of poverty stricken corneal blind to get vision and which is still running successfully across NCR and neighbouring rural areas, Tej is set to launch this first-of-its-kind initiative in North India.

23 Jul 2012

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, the Foundation Fighting Blindness Clinical Research Institute (FFBCRI) formerly known as the National Neurovision Research Institute (NNRI).

23 Jul 2012

BioDiem presents positive findings of their eye disease drug at international conference

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.

22 Jul 2012

In Florida, Obama attacks Romney on Medicare plan

Drawing on traditional Democratic campaign themes, President Barack Obama criticized GOP plans to transform Medicare into a "voucher program" and to repeal the 2010 health law.

21 Jul 2012

Number of blind persons decline in Germany

The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches -rzteblatt International.

21 Jul 2012

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Chief of the Mass. Eye and Ear and Mass. General Hospital's Departments of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School.

21 Jul 2012

Views on health reform: U.S. not getting value for its spending; Cutting doctors' school debt to curb costs

When it comes to healthcare, Americans are not getting a lot of value for their money. The United States spends 17.6% of its gross domestic product, nearly twice the average of the nations in the Organization for Economic Cooperation and Development. But life expectancy in the United States in 2010, at 78.7 years, is below the OECD average of 79.8 years. The U.S. infant mortality rate is higher than in most developed countries -; it is higher than the rates in Greece, Hungary and Slovakia.

21 Jul 2012

Ablation technique destroys eye of the storm

Researchers have developed a new technology that could significantly improve the success rate of procedures to treat atrial fibrillation.

20 Jul 2012

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.

20 Jul 2012

TLC announces first Laser Cataract Surgeries to be performed in Canada

TLC Laser Eye Centers is excited to announce the first Laser Cataract Surgeries to be performed in Canada, using an approved femtosecond laser, will take place at TLC's Mississauga center on July 24, 2012.

20 Jul 2012

Eye News and Research

Latest Eye News and Research

AIDS 2012 plenary speakers call for innovative financing, continued research for HIV cure

Obama skipping AIDS conference; Black community still bearing high burden of the disease

Assistant Sec. of Health Koh addresses AIDS 2012 plenary; HHS Sec. Sebelius speaks at Washington Post event

AAQ chemical temporarily restores vision in blind mice

AHAF announces glaucoma and macular degeneration research grants

Early-age cataract surgery increases central corneal thickness

Microneedles can deliver drug formulations into the eye

Ocular Therapeutix announces results from sustained release OTX-TP1 study on glaucoma

Tiny microneedles to treat macular degeneration

Insights on neural mechanisms behind guidance of attention

Noted philanthropist to launch mobile eye clinic in North India

Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial

BioDiem presents positive findings of their eye disease drug at international conference

In Florida, Obama attacks Romney on Medicare plan

Number of blind persons decline in Germany

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

Views on health reform: U.S. not getting value for its spending; Cutting doctors' school debt to curb costs

Ablation technique destroys eye of the storm

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

TLC announces first Laser Cataract Surgeries to be performed in Canada

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in